Level 3 plus
I am a CE-certified medical device
I am safely connected
I have proven my social-economic evidence and get reimbursed by NIHDI
I am safely connected
I have proven my social-economic evidence and get reimbursed by NIHDI
Downloads
Languages
EN
ES
FR
NL
General description
Additional info
Media
Financing
General description (provided by company)
Main purpose
Cureety is a medical remote monitoring platform dedicated to adult cancer patients. Its main purpose is to remotely monitor patients’ health status during oncology treatment, particularly to support the early detection of treatment-related symptoms and adverse events.
Patients regularly report their health status and symptoms through questionnaires adapted to their treatment. The information collected is assessed according to medical criteria and may generate alerts for healthcare professionals, enabling earlier intervention when necessary.
Where can this information be found?
Patient questionnaires and symptom monitoring are available directly in the application. Results, symptom evolution and alerts are accessible to healthcare professionals through the Cureety remote monitoring interface.
Patients regularly report their health status and symptoms through questionnaires adapted to their treatment. The information collected is assessed according to medical criteria and may generate alerts for healthcare professionals, enabling earlier intervention when necessary.
Where can this information be found?
Patient questionnaires and symptom monitoring are available directly in the application. Results, symptom evolution and alerts are accessible to healthcare professionals through the Cureety remote monitoring interface.
Target audience
The Cureety remote monitoring platform is intended for adult patients with cancer receiving oncology treatments, including intravenous or oral anticancer therapies. It enables healthcare professionals to remotely monitor patients’ health status, symptoms and potential treatment-related adverse events, helping care teams identify situations requiring early intervention.
Approach
Cureety TechCare is based on a remote patient monitoring methodology designed to regularly collect symptoms and adverse events reported by patients with cancer. Patients complete follow-up questionnaires tailored to their treatment or care pathway. The questions and answers are based on the CTCAE (Common Terminology Criteria for Adverse Events) classification to assess the nature and severity of the symptoms and adverse events reported.
The main data collected include patient identification and follow-up data, information relating to their treatment and care pathway, as well as their responses to questionnaires concerning the symptoms and adverse events they experience.
Each response is assigned a score that takes into account, in particular, the severity of the adverse event. The Cureety TechCare algorithm analyses these responses and calculates an indicative clinical classification of the patient’s condition, making it possible to identify and prioritise situations that may require further assessment by the healthcare team.
These data are collected for the purpose of enabling remote patient monitoring, facilitating the early identification of adverse events related to cancer or its treatment, helping healthcare professionals prioritise patient follow-up, and strengthening communication between the patient and the healthcare team. Cureety TechCare is used as a complement to standard medical follow-up and does not provide a medical diagnosis.
The main data collected include patient identification and follow-up data, information relating to their treatment and care pathway, as well as their responses to questionnaires concerning the symptoms and adverse events they experience.
Each response is assigned a score that takes into account, in particular, the severity of the adverse event. The Cureety TechCare algorithm analyses these responses and calculates an indicative clinical classification of the patient’s condition, making it possible to identify and prioritise situations that may require further assessment by the healthcare team.
These data are collected for the purpose of enabling remote patient monitoring, facilitating the early identification of adverse events related to cancer or its treatment, helping healthcare professionals prioritise patient follow-up, and strengthening communication between the patient and the healthcare team. Cureety TechCare is used as a complement to standard medical follow-up and does not provide a medical diagnosis.
Connectivity to sensors and platforms
Currently, Cureety is not directly connected to medical devices or connected devices that automatically measure physiological parameters such as blood pressure, temperature or other vital signs.
Integration with this type of device is currently being evaluated and is part of Cureety’s planned developments in the near to medium term. These developments will make it possible to connect Cureety with various medical devices and enrich remote patient monitoring with additional physiological data (Body temperature, blood pressure, etc.).
Integration with this type of device is currently being evaluated and is part of Cureety’s planned developments in the near to medium term. These developments will make it possible to connect Cureety with various medical devices and enrich remote patient monitoring with additional physiological data (Body temperature, blood pressure, etc.).
Financing and pricing model
Cureety’s development and maintenance are funded through a B2B business model based on two main components.
The first is the implementation of the solution and its integration into the healthcare provider’s IT system. This is a fixed, one-time implementation fee charged at deployment.
The second is a monthly fee per patient, charged for the duration of the patient’s remote monitoring period.
The application is not funded through in-app purchases and patients are not charged directly. The service is funded by the healthcare provider. Where oncology remote monitoring is subject to a reimbursement mechanism, the healthcare provider receives the reimbursement, which contributes to funding the service.
The first is the implementation of the solution and its integration into the healthcare provider’s IT system. This is a fixed, one-time implementation fee charged at deployment.
The second is a monthly fee per patient, charged for the duration of the patient’s remote monitoring period.
The application is not funded through in-app purchases and patients are not charged directly. The service is funded by the healthcare provider. Where oncology remote monitoring is subject to a reimbursement mechanism, the healthcare provider receives the reimbursement, which contributes to funding the service.
Adoption abroad
Cureety is already widely deployed internationally, with a particularly strong presence in France and ongoing development across several European countries.
In France, Cureety is currently used in more than 220 hospital groups across the country and enables the monitoring of nearly 50,000 patients. The platform has benefited from reimbursement in France for nearly three years, within the framework of medical remote monitoring.
In the Netherlands and Luxembourg, pilot phases and test projects are currently underway in several hospitals, despite the absence of specific reimbursement for oncology remote monitoring to date.
In Italy, Cureety is also beginning to be deployed in two major hospital centres. In Portugal, partnerships with several hospitals are currently being launched. In both countries, there is currently no specific reimbursement for the platform.
In Switzerland, several pilot projects are also being developed, without specific reimbursement at this stage.
In the United States, Cureety is used by several thousand patients. This presence has been further strengthened through the acquisition of Pre-Imagine Care, which was already well established in the US market, where certain remote monitoring services benefit from partial funding or reimbursement.
Cureety is also continuing its European expansion, with the German market expected to open shortly.
In France, Cureety is currently used in more than 220 hospital groups across the country and enables the monitoring of nearly 50,000 patients. The platform has benefited from reimbursement in France for nearly three years, within the framework of medical remote monitoring.
In the Netherlands and Luxembourg, pilot phases and test projects are currently underway in several hospitals, despite the absence of specific reimbursement for oncology remote monitoring to date.
In Italy, Cureety is also beginning to be deployed in two major hospital centres. In Portugal, partnerships with several hospitals are currently being launched. In both countries, there is currently no specific reimbursement for the platform.
In Switzerland, several pilot projects are also being developed, without specific reimbursement at this stage.
In the United States, Cureety is used by several thousand patients. This presence has been further strengthened through the acquisition of Pre-Imagine Care, which was already well established in the US market, where certain remote monitoring services benefit from partial funding or reimbursement.
Cureety is also continuing its European expansion, with the German market expected to open shortly.
Pathology
Cancer
Functions
Alerts & Notifications
Data Sharing
Health Tracking
Online Appointments
Online Prescriptions
Remote Clinical Monitoring
Users
Men
Women
Elderly
Clinicians
Additional info
Compliance to M3 criteria
This application has completed levels M1 and M2 of the pyramid, and the company declares to meet the criteria for mobile medical applications that NIHDI has set within the following specific care process:
Compliance to M1 criteria
CE certification
Certificate granted on 07/09/2026
Certificate valid till 31/12/2028
Class type of medical device (More info): Class 1
ISO Standards:
FAMHP registration and notification
Company registration number at FAMHP: 74889
Product identification code at FAMHP: 1022834910
General Data Protection Regulation (More info)
Reference publication
https://ascopubs.org/doi/10.1200/JCO.2023.41.16_suppl.1605
User instructions
Cureety TechCare is a medical device software for remote patient monitoring intended for adult patients with cancer. It is made available to the patient by their healthcare team to ensure regular monitoring of their health status during treatment, in addition to standard medical consultations.
After activating their account, the patient accesses Cureety via a web interface or the mobile application. At a frequency defined by the healthcare team, the patient completes a follow-up questionnaire consisting of 15 to 25 questions, tailored to their care pathway and treatment. The patient reports the symptoms and adverse effects they experience, as well as their level of severity.
The responses are analysed by Cureety TechCare in order to provide information adapted to the patient’s situation. For mild or moderately severe symptoms, practical advice may be provided. In the event of more severe symptoms, the patient is advised to contact their healthcare team, and an alert is sent to healthcare professionals via their Cureety interface.
Cureety TechCare is a tool designed to support self-monitoring and communication between the patient and their healthcare team. It does not make any diagnosis and does not replace the judgement of a healthcare professional, medical consultations, or the usual emergency care procedures.
Use of the solution requires an Internet connection and a compatible device. Personal and health data are protected by appropriate technical and organisational measures and are hosted in accordance with the applicable requirements for health data.
After activating their account, the patient accesses Cureety via a web interface or the mobile application. At a frequency defined by the healthcare team, the patient completes a follow-up questionnaire consisting of 15 to 25 questions, tailored to their care pathway and treatment. The patient reports the symptoms and adverse effects they experience, as well as their level of severity.
The responses are analysed by Cureety TechCare in order to provide information adapted to the patient’s situation. For mild or moderately severe symptoms, practical advice may be provided. In the event of more severe symptoms, the patient is advised to contact their healthcare team, and an alert is sent to healthcare professionals via their Cureety interface.
Cureety TechCare is a tool designed to support self-monitoring and communication between the patient and their healthcare team. It does not make any diagnosis and does not replace the judgement of a healthcare professional, medical consultations, or the usual emergency care procedures.
Use of the solution requires an Internet connection and a compatible device. Personal and health data are protected by appropriate technical and organisational measures and are hosted in accordance with the applicable requirements for health data.
Components of the application
Web applicationMedical device
Complaints handling
Via e-mail: info@cureetry.comVia telephone: 0033766723047